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Recent  experiments  from  this  laboratory  have  revealed  a  special  sensitivity  of 
immature, differentiating B lymphocyte populations to the induction of immunolog- 
ical tolerance. Thus, whether the cells were derived from newborn mouse spleen (1, 
2);  the differentiating pool from adult  mouse bone marrow  (2, 3); or the spleens of 
lethally irradiated mice being repopulated with fetal liver stem cells (4), they could be 
tolerized  by  minute  concentrations  of antigen,  which  left  mature  B  cells  either 
unaffected or  immunized.  These  findings,  which  were  interpreted as  favoring the 
clonal abortion theory of immunological tolerance (3), have recently been independ- 
ently confirmed and extended (5-9), (and some aspects disputed) using each of these 
three  systems.  Support  for  the  basic  concept  has  also  come  from  the  use  of the 
universal tolerogen, anti-# chain antibody (10-11). 
Our attempts to study the cellular mechanisms underlying this tolerance-susceptible 
phase in the life history of the B cell have been handicapped by two related factors. 
First, all the cell populations that have been tolerized have been heterogeneous cell 
mixtures,  including  stem  cells,  pre-B cells,  and  Ig-positive lymphocytes of varying 
degrees of maturity;  as well as B cells belonging to different functional subsets and 
displaying widely varying affinities for the tolerizing epitope. Second, in our hands, 
effective tolerance induction using such cell mixtures has required coincubation of 
cells with antigen for at least 36 h, in marked contrast to some models (5, 7), raising 
the possibility that  the target cell for tolerance induction was  a  precursor and  not 
itself a functional B cell. 
For these reasons, we have developed methods for the enrichment ofhapten-specific 
B lymphocytes applicable to both mature and immature cell populations (12, 13). We 
now report that  such  hapten-specific B  cells, precultured at  limit  dilution, can be 
rendered tolerant within 8 h  in vitro if derived from a newborn mouse spleen, while 
remaining normally reactive if derived from the adult. 
Materials and Methods 
Animals.  Inbred specific pathogen free mice were used in all experiments. CBA Ca/H Wehi 
mice, aged either 8- to 10-wk (adults), or 4-6 days (neonates), were used as spleen donors. (CBA 
×  BALB/c)F1 hybricls, aged 4- to 6-wk, were used as thymus donors. 
Antigens.  The hapten fluorescein (FLU) 1  was coupled on to human gamma globulin  (HGG) 
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t Abbreviations used in this paper: B lymhocyte,  bone marrow-derived  lymphocyte; FACS, fluorescence- 
activated cell sorter; FLU, fluorescein; HGG, human gamma globulin; LPS, lipopolysaccharide; PFC, 
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(Cohn Fraction II, Commonwealth Serum Laboratories, Parkville, Australia), and polymerized 
flagellin  (POL)  as  previously  described  (13). The  conjugate  used  as  the  tolerogen  in  all 
experiments  except  where otherwise specified,  contained  3.6  mol of FLU  per mol of HGG 
(FLU3.nHGG). 
Cell Suspensions.  Spleen and thymus cell suspensions were prepared as previously described 
(14). Thymus cells were treated with anti-Ia serum and complement to eliminate contaminating 
B cells before their use as filler cells in the microculture system. 
Cell Fractionat,on Methods.  FLU-gelatin fractionation, as previously described  (12-14), was 
sometimes followed by a second cycle of enrichment of cells of high FLU-binding avidity using 
the fluorescence-activated cell sorter (FACS) (FACS II, Becton Dickinson Electronics Labora- 
tories,  Mountain View, Calif.), as previously described (13). The top 15-20%  most fluorescent 
cells were sorted and after treatment with collagenase to remove adherent antigen, cells were 
placed into tissue  culture. 
Tissue Culture Procedures.  The  microculture system  used  for the limit  dilution  analysis of 
clonable anti-hapten  precursors in both unfractionated and FLU-gelatin fractionated spleen 
cell  populations  has been  described  in  detail  elsewhere  (13,  14). Briefly,  5  ×  103-2  ×  104 
unfractionated or 10-100 prefractionated spleen cells were cultured in the presence of anti-Ia 
treated thymus filler cells and 0.1 #g/ml of FLUI-POL was used as the challenge antigen either 
immediately or after putative tolerogenesis.  FLU-specific PFC determinations were performed 
62-66 h after challenge. 
Basic Protocol  for Tolerance Induction.  Unfractionated spleen cells or FLU-gelatin fractionated 
spleen cells were cultured at limit dilution in the presence of thymus filler cells (3  ×  106 ml) in 
culture medium containing various concentrations of FLU-HGG. 
After a period usually of 24 h, the supernatant medium of each well was carefully removed 
and replaced with 0.2 ml of fresh culture medium containing the immunogen FLU-POL (0.1 
#g/ml), and further anti-Ia treated thymocytes, (7 ×  106 cells/ml). Cultures were assayed after 
a  further  62-66  h.  In some experiments  20 /~g/ml Escherichia coli lipopolysaccharide  (LPS) 
(Difco Laboratories, Detroit, Mich.) or 0.1/~g/ml of4-hydroxy-3-iodo-5 nitrophenyi-POL (NIP- 
POL) was used as a challenge. 
Assay for Anti-Hapten Plaque-Forming Cells (PFC).  Each individual culture well was assayed 
for directly hemolytic anti-FLU PFC as previously described (13,  14) using the Cunningham 
liquid monolayer method to reveal plaque formation. The frequency of clonable anti-FLU PFC 
precursors was then calculated by Poisson analysis (14). 
Results 
Tolerance  Induction  in  Hapten-Specific  Cells  Prepared  by  FLU-Gelatin  Fractionation. 
Unfractionated  newborn spleen cells showed only 30% reduction in clone frequency 
after 24 h  with 5/lg/ml  of FLU-HGG (results not shown). Next, cells from newborn 
or adult  spleen  were  fractionated  with  the  FLU-gelatin  technique.  This  achieves  a 
mean enrichment  of clonable anti-FLU-PFC precursors of 130-fold for adult  spleen 
and  560-fold  for  newborn  spleen  (13).  The  FACS  profile  of  the  two  enriched 
populations labeled with FLU4 gelatin shows an identical degree of heterogeneity in 
antigen-binding  avidity.  Cells  harvested  by the  technique  are  >95%  Ig-positive in 
both  cases.  Using  the  same  limit  dilution  prespreading  technique,  the  cells  were 
exposed for 24 h to various concentrations of FLU-HGG or to no added antigen prior 
to immunogenic challenge with  FLU-POL. The frequency of anti-FLU PFC clones 
was  determined  66  h  after  the  addition  of FLU-POL  (Fig.  1).  With  adult  FLU- 
enriched cells, no reduction in the frequency of anti-FLU PFC clones was detected at 
any  concentration  below  25  /~g/ml.  Increasing  concentrations  of tolerogen  caused 
increasing degrees of reduction in clone frequency among the newborn FLU-specific 
cells. A  50% effect was seen at a  concentration of about 0.08/~g/ml of antigen. With 
adult FLU-enriched cells (results of two experiments, data not shown) 50% reduction G. J.  V.  NOSSAL  AND  BEVERLEY  L.  PIKE 
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Fro.  1.  Effect of 24 h exposure to increasing concentrations of FLUs.s-HGO before immunogenic 
challenge on the cloning frequency of anti-FLU PFC precursors in FLU-enriched cells  from adult 
(O)  and  neonatal  (0)  spleen  donors.  Data  shown for adults  represents a  pool of four to  seven 
experiments and  for neonates,  a  pool of four experiments. The  average  value obtained  in  two 
experiments is given where no error bars are shown. 
required 80 #g/ml of antigen. Thus, despite their equivalent antigen-binding capacity, 
the immature hapten-enriched cells were  1,000-fold more sensitive to tolerogenesis 
than adult hapten-enriched cells. 
Effects of Challenge by Antigen or LPS after Tolerogenesis.  Studies by Cambier et al. (7) 
have  claimed  that  immature T-dependent  B  cells  are  more  sensitive  to  tolerance 
induction than  their  adult  counterparts,  but  that  both  immature  and  mature  T- 
independent  cells  are  equally  and  extremely  sensitive.  As  the  polyclonal  B-cell 
activator, LPS, appears  to be capable of substituting for some T-cell functions, we 
challenged  FLU-enriched  B-cell  populations  (that  had  been  tolerized with  FLU- 
HGG) with either FLU-POL or LPS. The results (Table I) show that an equivalent 
degree of tolerance was obtained with either challenge system in the neonatal FLU- 
enriched  cells without  any reduction  in  responsiveness  being  shown  in  the  adult 
population. Furthermore, the presence of LPS during the tolerogenesis phase abro- 
gated the tolerogenic influence of FLU-HGG (results not shown), in agreement with 
Louis et al. (15). 
Tolerance  Induction  in  Cells  Sequentially  Fractionated on  FLU-Gelatin  Dishes  and 
FACS.  Previous work (13) has shown that when FLU:gelatin fractionated B cells are 1164  TOLERANCE  INDUCTION IN HAPTEN-SPECIFIC B LYMPHOCYTES 
TABLe I 
Comparative Effects of Antigen and LPS as Challenge Stimuh  for Tolerized, Hapten-Enriched B Cells 
Concentration  Frequency of anti-FLU PFC precursor (×  10  -a) 
of FLUa.sHGG 
during precul- 
ture, p,g/ml 
Adult enriched cells challenged with:  Neonatal enriched cells challenged with: 
FLU-POL  LPS  FLU-POL  LPS 
0  25.0  23.9  11.0  15.6 
5  22.4  29.5  3.73  4.29 
1  22.4  29.5  4.74  8.17 
0.2  19.4  19.2  5.11  6.06 
FLU-enriched cells were precultured in the presence or absence of tolerogen as indicated for 24 h before 
immunogenic challenge with either 0.1 #g/ml of FLU-POL or 20 #g/ml of LPS. The frequency of anti- 
FLU PFC precursors was determined 3 days after immunogenic challenge. Results shown are from one 
representative experiment. 
relabeled with FLU-gelatin and sorted in the FACS such that the  10% of cells  with 
the highest fluorescence intensity are collected, there is a further increment by a factor 
of 5 in the frequency of clonable anti-FLU PFC precursors.  The next-lower  10% in 
fluorescence intensity show a  slightly lower frequency.  Using newborn spleen  cells, 
there are some logistic difficulties in collecting enough cells  for extensive experimen- 
tation, as 200 spleens yield only 15  ×  l0  s cells,  of which 2  X  l0  s can be recovered 
from  FLU-gelatin  fractionation.  Therefore,  in  the  sequential  fractionation  experi- 
ments to be described we used the 15-20% most intensely fluorescent cells. Again such 
cells  were distributed at limit dilution and exposed to tolerogen for 24 h, challenged 
with FLU-POL as described, then assayed for anti-FLU PFC after 3 days of further 
culture.  The results  (Table II) indicate that the sequentially enriched, avidly FLU- 
binding cells  from newborn mice were even more susceptible to tolerance induction 
than the more heterogeneous FLU-gelatin binding cells. 
Kinetics of Tolerance Induction in Newborn Hapten-Specific Cells.  The kinetics of toler- 
ance  induction  were  studied  using  FLU-gelatin  fraetionated  cells.  Neonatal  FLU- 
enriched cells were exposed  to tolerogen for varying time  periods  before challenge 
with  FLU-POL.  A  no  antigen  control  was  included  at  each  time  point  and  the 
frequency of anti-FLU PFC precursors was determined  3 days after challenge. The 
pooled results of two experiments  (Fig.  2) show that with 5 #g/ml of FLU-HGG, no 
detectable tolerance was: induced within 2 h, but by 8 h, 60% of the clonable hapten- 
specific cells had been tolerized. Progressively longer exposure periods caused tolerance 
in somewhat more cells,  but a residuum of nontolerizable cells  persisted even after 48 
h tolerance induction. With 1 #g/ml of tolerogen, the pattern was similar but a longer 
exposure period was required to induce a  given degree of tolerance. 
Behavior of Hapten-Specific Cells from Mice of Various Ages.  Spleen cells from mice of 
various ages were fractionated on FLU-gelatin dishes. The FLU-enriched cell popu- 
lations were subjected  to 24 h  preculture in  the presence or absence of 5 #g/ml of 
FLUs.eHGG, then challenged with FLU-POL as described  followed by analysis for 
anti-FLU PFC clones 3 days later. The pooled results of two experiments showed that 
the  susceptibility  to  tolerance  induction  decreased  with  increasing  age  of spleen G..J.V.  NOSSAL AND BEVERLEY L.  PIKE 
TABLE II 
Tolerance Induction in FACS Sorted, FLU-Gelatin Prefractionated  Neonatal Spleen 
Cells 
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Concentration of 
FLUs.eHGG during 24 h 
preculture, #g/ml 
Frequency of anti-FLU PFC precursors as percent of 
control response 
FLU-GEL fractionated 
Top 15-20% FACS 
sorted enriched cells 
5  23  ±  8  ND 
1  35  ±  4  22  ±  7* 
0.2  41  ±  9  27  ±  9* 
0.04  54  ±  12  31:~ 
* Pool of three experiments. 
One experiment only. 
donors. At 9 days of age, 50% of the FLU-enriched cells were able to be tolerized; at 
16 days, only 25%; and by 30 days of age no tolerance could be shown. 
Effects  of Highly Multivalent  Hapten--HGG  Conjugates in  Tolerogenesis.  In all of our 
work on clonal abortion tolerogenesis to date, oligovalent hapten-protein conjugates 
have been used.  In the work of Cambier et al.  (7), which claims differences in the 
tolerizability of T-dependent and T-independent B cells, highly multivalent antigens 
were used.  Accordingly, we tested the effects of increasing the hapten  substitution 
rate on tolerance induction in B lymphocyte populations in our system. FLU-gelatin 
enriched cells were labeled at 0°C for 30 min with 5 #g/ml of either FLUs.6HGG or 
FLUlzHGG, and examined in FACS. The results (not shown) showed only a modest 
degree of enhanced fluorescence intensity among the cells exposed to the more highly 
substituted  reagent.  Next,  the  various  B-cell  populations  were exposed  to  varying 
concentrations of FLU12HGG for 24 h  in vitro before immunogenic challenge with 
FLU-POL and subsequent  analysis for anti-FLU PFC precursors as described. It is 
evident  (Fig.  3)  that  FLU12HGG  is  a  much  more  effective  tolerogen  than  the 
oligovalent  material.  For example,  a  concentration of 1 #g/ml  resulted  in  a  50% 
reduction in the frequency of anti-FLU PFC clones in unfractionated adult splenic B 
cells.  A slightly lower concentration was required to produce an equivalent reduction 
in adult  FLU-enriched splenic B cells.  With this tolerogen, the neonatal B cells are 
considerably more sensitive.  For example,  24 h  exposure to 0.2 #g/ml  FLU12HGG 
barely affected the subsequent cloning frequency of  adult FLU-enriched cells, whereas, 
with 0.2 #g/ml the subsequent cloning frequency of neonatal FLU-enriched splenic 
B cells was reduced to <20% of the control value. 
Discussion 
In  its simplest  form the clonal abortion theory of B  lymphocyte tolerance states 
that B cells mature from a condition where they are tolerizable but not immunizable 
to one where they are immunizable but not tolerizable. That this absolute formulation 
is not correct has been clear for some time, for example, because of the tolerizability 
of adult  spleen  B  cells  by  supraimmunogenic  doses  of multivalent  antigens  (16). 
Nevertheless, our previous work in this field (1-4) strongly suggested that there were 
circumstances under which the genesis of new, clonable B lymphocytes reactive to a 
particular antigen could be abrogated by exposure of the maturing cells to very low 1166  TOLERANCE INDUCTION IN HAPTEN-SPECIFIC B LYMPHOCYTES 
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FIG. 2.  Kinetics of tolerance induction in neonatal FLU-enriched cells exposed to either 5 ~g/ml 
(0)  or  1 ~g/ml  (O) of FLU3.nHGG before immunogenie challenge with FLU-POL. Precursor 
frequencies shown are normalized to the respective no tolerogen control frequency for each time 
point. Pooled results from two separate but identical experiments are shown. 
concentrations of antigen. In those experiments, no evidence was obtained to suggest 
that the small number of clonable B cells in the heterogeneous, differentiating mixture 
of cells was being affected. The noteworthy difference between the previous studies 
and  the  present  ones  is  that  we  have  now  placed  emphasis  on  a  much  more 
homogeneous population of cells harvested from immature animals. We have elimi- 
nated from consideration all the cells incapable of binding antigen, i.e.  all stem cells 
and pre-B cells, and furthermore have enriched for cells of high avidity for the FLU 
hapten.  This  has  allowed  the  delineation  of a  functionally  immature B  cell,  itself 
capable of tolerization by a  nonimmunogenic hapten-protein conjugate at low con- 
centrations  that  leave fully mature B  cells unaffected.  The existence of such  a  cell, 
simultaneously tolerizable and immunizable, had been strongly suggested by the work 
of Metcalf and Klinman (5, 8) but had not emerged through our prior work. In fact, 
our  identification  of  this  differentiation  state  removes  the  last  major  difference 
between their results and conclusions, and our own. 
The clonal  abortion  theory  must  now be restated  as in  Fig.  4.  We stand  by the 
previous results and conclusions which showed that neogenesis of direct progenitors of 
antibody-forming cells can be aborted, presumably through  an effect on those cells 
which  first display a  small amount of Ig receptors. The next stage of differentiation 
is an immature B cell. This differs from the pre-B cell in having sufficient Ig receptors 
to  adhere  to  hapten-gelatin  and  to  exhibit  membrane  immunofluorescence  when 
stained with anti-Ig sera. This immature B cell is still capable of being tolerized by 
low concentrations of oligovalent hapten-protein conjugates that  leave fully mature 
B cells of equivalent antigen-binding avidity unaffected (Fig.  1). However, this same G. J.  v. NOSSAL AND BEVERLEY L.  PIKE 
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FIG.  3.  Effect of 24 h  exposure to FLU12HGG before immunogenic challenge with FLU-POL  on 
the responses generated in unfractionated adult  (X  X)  and neonatal (0-------0) spleen cells, 
and adult  (X ..... ×) and neonatal (0-----0) FLU-gelatin enriched cells. Data shown represents 
normalized precursor frequency values from  one experiment. 
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immature  B  cell  is  capable  of being  triggered  by  appropriate  stimuli  such  as  T- 
independent  antigens or LPS. In contrast to a  pre-B cell, which  fails to mature into 
an Ig-positive clonable direct progenitor in the concomitant presence of tolerogen plus 
LPS  (3),  immature B cells as defined above have their tolerization threshold  raised 
when tolerogen and polyclonal activator are exhibited simultaneously. It is clear that 
the difference in susceptibility to negative signals of the various differentiation stages 
is relative rather than absolute. This is well illustrated by the effects of FLUx2HGG, 
an effective tolerogen of mature B cells (Fig. 3), or by the phenomenon of effector cell 
blockade (17,  18) where fully-differentiated antibody-secreting cells receive a negative 
signal  from  high  concentrations  of muhivalent  antigen,  and  lower  their  antibody 
secretion rate. 
As regards the  question  of the relative tolerizability of T-dependent  and T-inde- 
pendent  B cells, we maintain,  in contrast to Cambier et al.  (7), that T-independent 
immature B cells are more susceptible than their adult counterparts, whether oligo- 
valent  or  even  more  highly  tolerogenic  muhivalent  conjugates  are  used.  In  fact, 
preliminary investigations suggest that the tolerizability of B cells as measured by T- 
independent  and  T-dependent  challenge  systems closely  resemble  each  other.  We 
remain to be convinced that these two sorts of B cells really represent different lineages 
of differentiation rather than,  for example, sequential  maturation states.  Even that 1168  TOLERANCE  INDUCTION  IN  HAPTEN-SPECIFIC  B  LYMPHOCYTES 
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Fla.  4.  Restatement of the clonal abortion theory. 
possibility is rendered dubious by the efficient performance of fetal B cells in the T- 
dependent Metcalf and Klinman system (5). 2 
We  consider  that  the  present  system,  where  B  cells  of relatively  homogenous 
character and  with  high  avidity for antigen,  can be rendered tolerant within  8  h, 
represents a good opportunity to study the cellular mechanisms involved in tolerance 
induction of immature B cells. Our previous work was always handicapped by the 
long  time  in  culture  required  for  a  significant  effect.  Not  only  did  the  in  vitro 
maturation  of cells  make  it  difficult  to  determine  which  cell  was  actually  being 
affected by the tolerogen, but  also the death of cells in culture made it difficult to 
separate true effects from differential survival of cells.  Within the 8-h period for the 
present tolerogenesis regime, nonspecific death in control cultures is much less,  and 
studies of receptor dynamics and re-expression, or of effects on cell metabolism become 
much more feasible. 
Summary 
B  lymphocytes  with  receptors  specific  for  the  hapten  fluorescein  (FLU)  were 
prepared from the spleens of mice of various ages. For most experiments, a one-step 
fractionation procedure based on the adherence of FLU-specific cells to FLU-gelatin 
was  used.  For  some  experiments,  a  subset  of higher  FLU-binding  capacity  was 
prepared from the FLU-gelatin binding population through the use of the  fluores- 
cence-activated cell sorter (FACS). FLU-specific B cells were placed into microculture 
with either FLUa.6-human gamma globulin (FLUa.6HGG) or FLU12HGG usually for 
24 h  at  37°C.  The tolerogen was then removed and 0.1  #g/ml of a  T-independent 
antigen, FLU-polymerized flagellin, was substituted. 3 days later, cells were harvested 
from the microcultures and assayed for FLU-specific plaque-forming cells to determine 
any reduction in clonable hapten-specific B cells which the tolerogenesis treatment 
might have induced. 
The results showed that with FLU3.6HGG, hapten-specific newborn B cells could 
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be tolerized at  1,000-fold lower tolerogen concentrations than adult splenic B cells of 
equal antigen-binding capacity. The high-avidity subset was even more susceptible to 
tolerance induction. Tolerance could be induced within 8 but not within 2 h, and at 
lower  tolerogen  concentrations,  longer  periods  of tolerogenesis were required  for a 
given  effect.  Using  a  24-h  tolerogenesis  phase,  50%  reduction  in  clone  frequency 
among  newborn  FLU-gelatin  fractionated  cells  was  achieved  at  0.08  /~g/ml  of 
FLUa.6HGG. Tolerance induction  in immature B cells was inhibited by the concom- 
itant presence of a polyclonal B-cell activator, Escherichia coli lipopolysaccharide (LPS) 
but  tolerance  once  induced,  was  stable  to  challenge  with  LPS.  Tolerogenesis  was 
hapten specific. The proportion of tolerizable cells in spleens decreased with increasing 
age, reaching 50% at around 9 days. 
FLUI~HGG proved a  more powerful tolerogen than FLUs.6HGG. It had an effect 
on  adult  cells,  50%  reduction  in  clone  frequency  being noted  at  around  1 /~g/ml. 
However, and in contrast to results claimed for other T-independent  systems, there 
still was a major difference between immature and mature B cells, the immature cells 
displaying much greater sensitivity to tolerogenesis. 
The authors wish to acknowledge gratefully the excellent  technical assistance  of K. Bamford, 
H. Bathard, E. Cain, and H. Ward throughout these studies. 
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